A Randomized, Double-Blind, Active Controlled Clinical Trial of Switching to Vilazodone for Antidepressant-Associated Sexual Dysfunction
Phase of Trial: Phase IV
Latest Information Update: 29 Aug 2016
At a glance
- Drugs Vilazodone (Primary) ; Sertraline
- Indications Major depressive disorder; Sexual function disorders
- Focus Therapeutic Use
- 24 Aug 2016 Status changed from recruiting to discontinued.
- 04 Feb 2016 Planned End Date changed from 1 Jun 2017 to 1 Jun 2018, as reported by ClinicalTrials.gov record.
- 04 Feb 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017, as reported by ClinicalTrials.gov record.